BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:36 PM
 | 
Nov 17, 2008
 |  BC Extra  |  Top Story

UTHR down after treprostinil miss

United Therapeutics (NASDAQ:UTHR) fell $31.90 (35%) to $58.62 on Monday after oral treprostinil missed the primary endpoint in the Phase III FREEDOM-C trial to treat pulmonary arterial hypertension (PAH). The primary endpoint of the double-blind, international trial was median...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >